+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Oropharyngeal candidiasis as a marker for esophageal candidiasis in patients with cancer



Oropharyngeal candidiasis as a marker for esophageal candidiasis in patients with cancer



Clinical Infectious Diseases 27(2): 283-286



The present study was designed to determine the frequency of candidal esophagitis in cancer patients with oral thrush. Patients with clinically and microbiologically diagnosed oral candidiasis were evaluated by endoscopy for concurrent esophageal candidiasis. Esophageal involvement was documented by mucosal lesions, microbiological findings of candidal infection in smears of brushing material, positive cultures of brushing material, and histological evidence of mucosal invasion by the yeast. For 21 of the 22 patients studied, there were endoscopic and microbiological findings of candidal esophagitis. Cultures of the brushing material from all 22 patients were positive, while histological evidence was found for 14 patients. Only 10 of the patients had mild esophageal symptoms. It is concluded that oral thrush represents a reliable marker for esophageal candidiasis in patients with cancer. Routine endoscopy is not necessary to confirm the diagnosis; this procedure should be reserved for patients with persistent thrush and symptoms despite antifungal therapy.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 003221888

Download citation: RISBibTeXText

PMID: 9709877

DOI: 10.1086/514653


Related references

Oral candidiasis as a marker of esophageal candidiasis in the acquired immunodeficiency syndrome. Annals of Internal Medicine 104(1): 54-55, 1986

Management of oropharyngeal and esophageal candidiasis in patients with HIV infection. HIV Therapy 4(3): 325-343, 2010

Itraconazole vs ketoconazole in hiv positive patients with oropharyngeal and or esophageal candidiasis. Program & Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 32: 297, 1992

Oropharyngeal and esophageal candidiasis in immunocompromised patients: treatment issues. Clinical Infectious Diseases 26(2): 259-72; Quiz 273-4, 1998

Azole-resistant oropharyngeal and esophageal candidiasis in patients with AIDS. Aids 9(5): 533-534, 1995

Optimal management of oropharyngeal and esophageal candidiasis in patients living with HIV infection. Hiv/Aids 2: 89, 2010

Comparison of itraconazole and ketoconazole in HIV-positive patients with oropharyngeal or esophageal candidiasis. Chemotherapy 42(5): 374-383, 1996

Treatment of hiv positive patients with oropharyngeal and or esophageal candidiasis the results of a db study. Morisset, R A Ve Conference Internationale Sur Le Sida: Le Defi Scientifique Et Social; V International Conference on Aids: The Scientific And Social Challenge; Montreal, Quebec, Canada, June 4-9, 1262p International Development Research Centre: Ottawa, Ontario, Canada Illus Paper 474, 1989

Therapeutic options for the management of oropharyngeal and esophageal candidiasis in HIV/AIDS patients. HIV Clinical Trials 1(1): 47-59, 2001

Caspofungin susceptibility testing of isolates from patients with esophageal candidiasis or invasive candidiasis: relationship of MIC to treatment outcome. Antimicrobial Agents and ChemoTherapy 49(9): 3616-3623, 2005

Treatment of oropharyngeal and esophageal candidiasis with a new antifungal agent fluconazole in hiv infected patients. Current Therapeutic Research 47(1): 81-87, 1990

Gentian violet, ketoconazole and nystatin in oropharyngeal and esophageal candidiasis in Zairian AIDS patients. Annales de la Societe Belge de Medecine Tropicale 72(1): 45-52, 1992

Epidemiological clinical endoscopic and mycological findings in oropharyngeal and esophageal candidiasis in hiv infected patients. Istituto Superiore Di Sanita Vii International Conference on Aids: Science Challenging Aids; Florence, Italy, June 16-21, 464p (Vol 1); 460p (Vol 2) Istituto Superiore Di Sanita: Rome, Italy Paper : 266b, 1991

Differential expression of CH809 by Candida albicans during oropharyngeal candidiasis and disseminated candidiasis. Abstracts of the General Meeting of the American Society for Microbiology 101: 384, 2001

Azole-resistant, progressive oropharyngeal and esophageal candidiasis in patients with AIDS A re-emerging indication for amphotericin B. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 34: 213, 1994